Proteomic analysis of acrylamide-protein adduct formation in rat brain synaptosomes

David S. Barber, Richard M. LoPachin

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Evidence suggests that the neurological defects (gait abnormalities, foot splay, and skeletal muscle weakness) associated with acrylamide (ACR) intoxication are mediated by impaired neurotransmission at central and peripheral synapses. ACR can form adducts with nucleophilic residues on proteins and thereby alter corresponding structure and function. To evaluate protein adduction in nerve terminals as a possible mechanism of action, recombinant N-ethylmaleimide sensitive factor (NSF) was exposed in vitro to ACR (10 μmol) and mass spectrometry (MS) was used to identify adduct sites. MS analyses demonstrated that ACR formed adducts with sulfhydryl groups on cysteine residues (carbamoylethylcysteine, or CEC) of NSF. Ex vivo incubation of whole brain synaptosomes with ACR (0.001-1.0 M) produced concentration-dependent increases in CEC that were inversely correlated to reductions in neurotransmitter release that occurred over the same neurotoxicant concentration range. In synaptosomes isolated from rats intoxicated at a higher (50 mg/kg per day × 3, 5, 8, or 11days) or a lower (21 mg/kg per day × 14, 21, or 28 day) ACR dose rate, CEC levels increased progressively up to a moderate level of neurotoxicity. To identify protein adducts, synaptosomal proteins labeled by ex vivo 14C-ACR exposure were separated by gel electrophoresis and probed by immunoblot analysis. Results showed that NSF and the SNARE protein, SNAP-25, were tentative ACR targets. Subsequent experiments indicated that ACR exposure increased synaptosomal levels of the 7S SNARE core complex, which is consistent with inhibition of NSF, SNAP-25 function, or both. These data suggest that adduction of cysteine residues on NSF and certain SNARE proteins might be causally involved in the nerve terminal dysfunction induced by ACR.

Original languageEnglish (US)
Pages (from-to)120-136
Number of pages17
JournalToxicology and Applied Pharmacology
Volume201
Issue number2
DOIs
StatePublished - Dec 1 2004

Fingerprint

Synaptosomes
Acrylamide
Proteomics
Rats
Brain
N-Ethylmaleimide-Sensitive Proteins
Proteins
SNARE Proteins
Mass spectrometry
Cysteine
Mass Spectrometry
Muscle Weakness
Electrophoresis
Gait
Synaptic Transmission
Synapses
Neurotransmitter Agents
Muscle
Foot
Skeletal Muscle

Keywords

  • Mass spectrometry
  • Neurotoxicity
  • Neurotransmission
  • Protein adducts
  • Proteomics
  • Toxic axonopathy

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Proteomic analysis of acrylamide-protein adduct formation in rat brain synaptosomes. / Barber, David S.; LoPachin, Richard M.

In: Toxicology and Applied Pharmacology, Vol. 201, No. 2, 01.12.2004, p. 120-136.

Research output: Contribution to journalArticle

@article{8cd3aec194864098a9e08927f4a158ec,
title = "Proteomic analysis of acrylamide-protein adduct formation in rat brain synaptosomes",
abstract = "Evidence suggests that the neurological defects (gait abnormalities, foot splay, and skeletal muscle weakness) associated with acrylamide (ACR) intoxication are mediated by impaired neurotransmission at central and peripheral synapses. ACR can form adducts with nucleophilic residues on proteins and thereby alter corresponding structure and function. To evaluate protein adduction in nerve terminals as a possible mechanism of action, recombinant N-ethylmaleimide sensitive factor (NSF) was exposed in vitro to ACR (10 μmol) and mass spectrometry (MS) was used to identify adduct sites. MS analyses demonstrated that ACR formed adducts with sulfhydryl groups on cysteine residues (carbamoylethylcysteine, or CEC) of NSF. Ex vivo incubation of whole brain synaptosomes with ACR (0.001-1.0 M) produced concentration-dependent increases in CEC that were inversely correlated to reductions in neurotransmitter release that occurred over the same neurotoxicant concentration range. In synaptosomes isolated from rats intoxicated at a higher (50 mg/kg per day × 3, 5, 8, or 11days) or a lower (21 mg/kg per day × 14, 21, or 28 day) ACR dose rate, CEC levels increased progressively up to a moderate level of neurotoxicity. To identify protein adducts, synaptosomal proteins labeled by ex vivo 14C-ACR exposure were separated by gel electrophoresis and probed by immunoblot analysis. Results showed that NSF and the SNARE protein, SNAP-25, were tentative ACR targets. Subsequent experiments indicated that ACR exposure increased synaptosomal levels of the 7S SNARE core complex, which is consistent with inhibition of NSF, SNAP-25 function, or both. These data suggest that adduction of cysteine residues on NSF and certain SNARE proteins might be causally involved in the nerve terminal dysfunction induced by ACR.",
keywords = "Mass spectrometry, Neurotoxicity, Neurotransmission, Protein adducts, Proteomics, Toxic axonopathy",
author = "Barber, {David S.} and LoPachin, {Richard M.}",
year = "2004",
month = "12",
day = "1",
doi = "10.1016/j.taap.2004.05.008",
language = "English (US)",
volume = "201",
pages = "120--136",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Proteomic analysis of acrylamide-protein adduct formation in rat brain synaptosomes

AU - Barber, David S.

AU - LoPachin, Richard M.

PY - 2004/12/1

Y1 - 2004/12/1

N2 - Evidence suggests that the neurological defects (gait abnormalities, foot splay, and skeletal muscle weakness) associated with acrylamide (ACR) intoxication are mediated by impaired neurotransmission at central and peripheral synapses. ACR can form adducts with nucleophilic residues on proteins and thereby alter corresponding structure and function. To evaluate protein adduction in nerve terminals as a possible mechanism of action, recombinant N-ethylmaleimide sensitive factor (NSF) was exposed in vitro to ACR (10 μmol) and mass spectrometry (MS) was used to identify adduct sites. MS analyses demonstrated that ACR formed adducts with sulfhydryl groups on cysteine residues (carbamoylethylcysteine, or CEC) of NSF. Ex vivo incubation of whole brain synaptosomes with ACR (0.001-1.0 M) produced concentration-dependent increases in CEC that were inversely correlated to reductions in neurotransmitter release that occurred over the same neurotoxicant concentration range. In synaptosomes isolated from rats intoxicated at a higher (50 mg/kg per day × 3, 5, 8, or 11days) or a lower (21 mg/kg per day × 14, 21, or 28 day) ACR dose rate, CEC levels increased progressively up to a moderate level of neurotoxicity. To identify protein adducts, synaptosomal proteins labeled by ex vivo 14C-ACR exposure were separated by gel electrophoresis and probed by immunoblot analysis. Results showed that NSF and the SNARE protein, SNAP-25, were tentative ACR targets. Subsequent experiments indicated that ACR exposure increased synaptosomal levels of the 7S SNARE core complex, which is consistent with inhibition of NSF, SNAP-25 function, or both. These data suggest that adduction of cysteine residues on NSF and certain SNARE proteins might be causally involved in the nerve terminal dysfunction induced by ACR.

AB - Evidence suggests that the neurological defects (gait abnormalities, foot splay, and skeletal muscle weakness) associated with acrylamide (ACR) intoxication are mediated by impaired neurotransmission at central and peripheral synapses. ACR can form adducts with nucleophilic residues on proteins and thereby alter corresponding structure and function. To evaluate protein adduction in nerve terminals as a possible mechanism of action, recombinant N-ethylmaleimide sensitive factor (NSF) was exposed in vitro to ACR (10 μmol) and mass spectrometry (MS) was used to identify adduct sites. MS analyses demonstrated that ACR formed adducts with sulfhydryl groups on cysteine residues (carbamoylethylcysteine, or CEC) of NSF. Ex vivo incubation of whole brain synaptosomes with ACR (0.001-1.0 M) produced concentration-dependent increases in CEC that were inversely correlated to reductions in neurotransmitter release that occurred over the same neurotoxicant concentration range. In synaptosomes isolated from rats intoxicated at a higher (50 mg/kg per day × 3, 5, 8, or 11days) or a lower (21 mg/kg per day × 14, 21, or 28 day) ACR dose rate, CEC levels increased progressively up to a moderate level of neurotoxicity. To identify protein adducts, synaptosomal proteins labeled by ex vivo 14C-ACR exposure were separated by gel electrophoresis and probed by immunoblot analysis. Results showed that NSF and the SNARE protein, SNAP-25, were tentative ACR targets. Subsequent experiments indicated that ACR exposure increased synaptosomal levels of the 7S SNARE core complex, which is consistent with inhibition of NSF, SNAP-25 function, or both. These data suggest that adduction of cysteine residues on NSF and certain SNARE proteins might be causally involved in the nerve terminal dysfunction induced by ACR.

KW - Mass spectrometry

KW - Neurotoxicity

KW - Neurotransmission

KW - Protein adducts

KW - Proteomics

KW - Toxic axonopathy

UR - http://www.scopus.com/inward/record.url?scp=8444241129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8444241129&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2004.05.008

DO - 10.1016/j.taap.2004.05.008

M3 - Article

VL - 201

SP - 120

EP - 136

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 2

ER -